Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution

NCT07105371 is registered in ClinicalTrials.gov with The Foundation for Orthopaedics and Regenerative Medicine as lead sponsor.

NCT NCT07105371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07105371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution
Lead sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Phase
Phase 1
Overall status
Completed
Start date
July 14, 2024
Completion date
May 14, 2026
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

motor disorders